Achilles Therapeutics plc American Depositary Shares

ACHL

...

ACHL: Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Show ACHL Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of ACHL by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ACHL's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Identification of clonal neoantigens and uses thereof Nov. 22, 2022

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on ACHL's company Twitter account

WallStreetBets

Number of mentions of ACHL in WallStreetBets Daily Discussion

ACHL News

Recent insights relating to ACHL

CNBC Recommendations

Recent picks made for ACHL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ACHL

Corporate Flights

Flights by private jets registered to ACHL